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Accuracy of Intraoperative Computed
Tomography in Deep Brain Stimulation—A
Prospective Noninferiority Study
Naomi I. Kremer, BS* ; D. L. Marinus Oterdoom, MD*;
Peter Jan van Laar, MD, PhD†; Dan Piña-Fuentes, MD*;
Teus van Laar, MD, PhD‡; Gea Drost, MD, PhD*‡;
Arjen L. J. van Hulzen, MS†; J. Marc C. van Dijk, MD, PhD*
Introduction: Clinical response to deep brain stimulation (DBS) strongly depends on the appropriate placement of the elec-
trode in the targeted structure. Postoperative MRI is recognized as the gold standard to verify the DBS-electrode position in
relation to the intended anatomical target. However, intraoperative computed tomography (iCT) might be a feasible alterna-
tive to MRI.
Materials and Methods: In this prospective noninferiority study, we compared iCT with postoperative MRI (24-72 hours after sur-
gery) in 29 consecutive patients undergoing placement of 58 DBS electrodes. The primary outcome was deﬁned as the difference in
Euclidean distance between lead tip coordinates as determined on both imaging modalities, using the lead tip depicted on MRI as
reference. Secondary outcomes were difference in radial error and depth, as well as difference in accuracy relative to target.
Results: The mean difference between the lead tips was 0.98  0.49 mm (0.97  0.47 mm for the left-sided electrodes and
1.00  0.53 mm for the right-sided electrodes). The upper conﬁdence interval (95% CI, 0.851 to 1.112) did not exceed the non-
inferiority margin established. The average radial error between lead tips was 0.74  0.48 mm and the average depth error
was determined to be 0.53  0.40 mm. The linear Deming regression indicated a good agreement between both imaging
modalities regarding accuracy relative to target.
Conclusions: Intraoperative CT is noninferior to MRI for the veriﬁcation of the DBS-electrode position. CT and MRI have their
speciﬁc beneﬁts, but both should be considered equally suitable for assessing accuracy.
Keywords: Accuracy, deep brain stimulation, intraoperative CT, movement disorders, stereotactic coordinates
Conﬂict of Interest: The authors report no conﬂict of interest concerning the materials or methods used in this study or the
ﬁndings speciﬁed in this paper.
INTRODUCTION
Deep brain stimulation (DBS) is a well-recognized and effective
neurosurgical treatment for various movement disorders. The clin-
ical effect of DBS largely depends on the appropriate placement
of the electrode in the targeted structure (1). Therefore, a correct
assessment of the electrode position with imaging techniques
during or directly after the surgical procedure is crucial, since it
can timely indicate a necessary repositioning of the electrode.
Magnetic resonance imaging (MRI) is considered to be the
gold standard to assess the electrode position after DBS implan-
tation (2–9). MRI offers detailed visualization of relevant brain
structures. However, image distortion caused by local magnetic
ﬁeld inhomogeneity may cause a nonconcentric artifact, usually
larger than the electrode itself, which could possibly have a
negative impact on the suitability of MRI for electrode position
assessment (8,10,11).
Intraoperative computed tomography (iCT) offers a high spatial
resolution and a good delineation of the DBS electrode, providing
a precise localization of the electrode (12). CT is signiﬁcantly
cheaper (13) and less time consuming than MRI. Furthermore,
while iCT is readily available in most hospital settings, access to
an intraoperative MRI is often limited.
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A number of studies have been conducted regarding the most
suitable imaging modality for assessing accuracy in DBS (10,14–16).
However, these studies had several methodological limitations,
such as nonconsecutive inclusions (10,16), only a retrospective
character (10,15,16), uncertainty about the duration between CT
and MRI scan (10,16) and the lack of sample size calculations
(10,14–16).
This study was designed to compare iCT (fused with preopera-
tive MRI (15,17–19)) with early postoperative MRI for electrode
position veriﬁcation in DBS surgery.
MATERIALS AND METHODS
Study Population and DBS Targets
We prospectively studied a single-institution series of 29 consec-
utive patients (mean age 58  13.6 years, range: 16-76) undergo-
ing bilateral DBS placement (58 electrodes) between November
2016 and April 2018. Thirty-eight electrodes were implanted in
the subthalamic nucleus (STN), 14 in the internal globus pallidus
(GPi), 4 in the zona incerta (ZI), and 2 in the thalamic ventral inter-
mediate nucleus (VIM).
Imaging and Targeting
DBS targeting was based on preoperative 3 T MRI (Philips
Intera, Eindhoven, the Netherlands), using the planning software
iPlan 3.6 (Brainlab, Feldkirchen, Germany). Targeting was indepen-
dently performed by two neurosurgeons. Preoperative stereotac-
tic CT images (Sensation 64, Siemens, Erlangen, Germany) using
the Leksell G frame (Elekta, Stockholm, Sweden) were transferred
to the iPlan software and subsequently fused with the preopera-
tive 3 T MRI to register the planned target in the stereotactic
coordinate system. During the surgical procedure, immediately
after bilateral lead placement, patients were brought to the Medical
Imaging Unit, in which iCT images were obtained on a diagnostic
CT suite (Sensation 64). A deviation from the intended target was
manually calculated based on the iCT scan, using the iPlan probe
view tool. If the lead was positioned <2 mm from the intended tar-
get, lead positioning was accepted. On the contrary, if a deviation
of ≥2 mm off-target was determined, lead repositioning was per-
formed immediately. Only one iCT veriﬁcation was performed per
patient. Afterwards, the internal pulse generator was implanted
under general anesthesia. Within 24 to 72 hours after surgery,
patients underwent 1.5 T-MRI (Aera, Siemens, Erlangen, Germany).
Refer to Table 1 for imaging protocol speciﬁcation.
The iCT and postoperative MRI datasets were fused to the pre-
operative stereotactic CT. The fusion of images by iPlan 3.6 runs
automatically, using a mutual information algorithm for dataset
correlation.
Lead Visualization and Localization
iPlan 3.6 was used to localize the leads. To improve visualiza-
tion, a new trajectory was planned along the center of the lead
artifact with a diameter of 1.2 mm, corresponding to the diameter
of the actual lead (1.27 mm).
Lead artifacts appear differently on iCT and MRI (Fig. 1). An
ellipsoid shaped artifact was seen on MRI, while a clear, well-
delineated hyperdense artifact was seen on iCT. On iCT, a speciﬁc
window level setting (Houndsﬁeld Unit (HU) level: 1100 HU, width:
50 HU) was chosen to maximize contrast between lead and sur-
rounding tissue, improving visualization. The lead position was
determined as the imaginary center of the artifact on both modal-
ities (Fig. 2). From the iCT and MRI datasets, the stereotactic coor-
dinates of the lead tip were obtained, taking the most caudal part
of the lead artifact as the lead tip position.
To study interobserver reliability, the plotting of the electrode
trajectories was repeated by a neuroradiologist for all patients.
Direct Comparison Between Modalities: Euclidean Distance,
Radial Error, and Depth
Lead tip coordinates were compared between both imaging
modalities. The Euclidean distance between lead tip positions as
determined on iCT and MRI was calculated for all electrodes.
Euclidean distance¼ √ ΔX2 +ΔY2 +ΔZ2 
Besides the Euclidean distance, radial error and depth were
assessed. Radial error is deﬁned as the 2D distance in X and Y
plane. For these assessments, the iCT lead was plotted into the
postoperative MRI. Via the iPlan probe view tool, radial distance
and depth were determined between the centers of both
lead tips.
Indirect Comparison Between Modalities: Accuracy Relative to
Target
Furthermore, the difference between both modalities and the
intended target was determined. Targets were assessed according
to the intended nucleus. The target is placed in the −1/+2 contact
spacing of the DBS lead when the target is in the STN, VIM, or ZI,
while in GPi stimulation, the intention is to insert the lead tip at
target.
In the STN, VIM, ZI leads (44 leads), coordinates of the −1/+2
contact spacing of the DBS lead were calculated using vector
2
Table 1. Imaging Protocol Speciﬁcation.
Imaging technique Scan protocol
Preoperative 3 T MRI 3D T1, 200 slices, slice distance 0.9 mm + T2, axial, coronal and sagittal planes, 30 slices, slice distance 2 mm, matrix
size: 260 × 320 × 160, voxel size: 0.75 mm × 0.75 mm × 1 mm
Preoperative CT Axial planes, 2 mm slice distance, 60 slices, matrix size: 512 × 512 × 64, voxel size: 0.488 mm × 0.488 mm × 2 mm
Intraoperative CT Axial planes, 0.5 mm slice distance, 270 slices with image reconstruction for brain parenchyma and (early)
hematoma assessment (5 mm connecting slices using the soft tissue algorithm), matrix size: 512 × 512 × 297,
voxel size: 0.488 mm × 0.488 mm × 0.5 mm
Postoperative 1.5 T MRI Axial and coronal planes, 30 and 15 slices respectively, 2.2 mm slice distance, matrix size: 290 × 320 × 27, voxel size:
0.719 mm × 0.719 mm × 2.2 mm
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geometry. The Euclidean distance between these coordinates and
the intended target coordinates were calculated, using the afore-
mentioned formula.
In the GPi leads (14 leads), the Euclidean distance between the
lead tip coordinates and the intended target coordinates were
calculated.
Statistical Analysis
The primary hypothesis was that iCT would be noninferior to
postoperative MRI for the veriﬁcation of the DBS lead position.
We determined a noninferiority margin of 2 mm. It has been
described in literature (20–22) that the weighted mean distance
between lead tips on CT and MRI is 1.50  0.50 mm. Accordingly,
we estimated a difference of 0.50 mm or more to be clinically
relevant for the accuracy estimation. To calculate our sample size,
we used a Cohen’s d (mean difference/standard deviation, d) of
1. Based on a power (1 − β) of 0.95 and an alpha signiﬁcance
level (α) of 0.025, we estimated that 16 electrode distances were
needed for our statistical analysis.
Calculations were performed according to the formula (23):
n number of electrodesð Þ¼ f α, βð Þ× 2× σ2=d2
In which f is the function of α and β, σ is the standard devia-
tion, and d is the noninferiority limit.
Thus, 29 participants implanted with 58 electrodes had sufﬁ-
cient power determine the possible noninferiority of iCT to MRI.
Euclidean distances resulted from the direct comparison of iCT
and MRI leads, were compared with the mean distance previously
3
Figure 1. DBS leads of the same patient on MRI (left) and on iCT (before windowing; right). The MRI artifact is depicted as a hypodense signal whereas the CT
artifact is hyperdense. [Color ﬁgure can be viewed at wileyonlinelibrary.com]
Figure 2. Lead visualization and plotted lead trajectory on MRI (left) and iCT (after windowing; right) in the same patient using the probe view in iPlan. The red
and green lines represent the left-sided and the right-sided lead-artifact, respectively. [Color ﬁgure can be viewed at wileyonlinelibrary.com]
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reported in literature using a one sample right-tailed t-test. Conﬁ-
dence intervals (CIs) were calculated to determine whether the
upper limit of the CI exceeded the noninferiority margin.
For the indirect comparison between modalities, a linear Deming
regression was performed between the error from target to lead in
Euclidean distance, estimated both using MRI and CT. The variances
were assumed to be similar between both modalities (lambda = 1)
and the level of signiﬁcance alpha was determined at 0.05. The cor-
relation between both techniques was estimated using Pearson’s r.
The statistical analysis was performed using R version 3.5.1 and
the statistical package mcr. Descriptive statistics are given with
mean and standard deviation. Intraclass correlation (ICC) with
95% CI were obtained for two raters for interobserver reliability.
According to Dutch legislation, the local research ethical board
stated that the study was not submitted to the Medical Research
Involving Human Subjects Act (WMO).
RESULTS
Direct Comparison Between Modalities: Euclidean Distance,
Radial Error, and Depth
In our cohort, one lead position was revised after initial implan-
tation because the lead was placed 2 mm too superﬁcial as deter-
mined on iCT. After placing the lead 2 mm more caudal, an
additional iCT was not acquired. Therefore, this lead was excluded
and analysis was performed in 57 leads. The average Euclidean
distance between lead tips was 0.98  0.49 mm; 0.97  0.47 mm
for the left-sided electrode and 1.00  0.53 mm for the right-
sided electrode (Table 2). The calculated mean Euclidean dis-
tances were not signiﬁcantly higher than the reported weighted
mean (t56 = −7.9335, p = 1). The upper CI (0.851-1.112) did not
exceed the noninferiority margin established.
The average radial error between lead tips was 0.74  0.48 mm,
whereas the average depth error was determined to be 0.53 
0.40mm.
Indirect comparison between modalities: accuracy relative to
target
On iCT, the average Euclidean distance between the DBS lead
and the intended target was 1.71  0.61 mm; 1.98  0.61 mm for
the left-sided electrode and 1.40  0.45 mm for the right-sided
electrode.
OnMRI, the average Euclidean distance between the DBS lead and
the intended target was 1.94 0.74 mm; 2.19 0.61 mm for the left-
sided electrode and 1.70 0.79mm for the right-sided electrode.
The linear Deming regression indicated a good agreement
between both imaging modalities (intercept 0.066, CI −0.3607 to
0.5310, slope 0.08362, CI 0.6047 to 1.0326). The CI of the intercept
contains 0, which indicates no signiﬁcant accuracy difference
between CT and MRI, while the CI of the slope contains 1, which
indicates no signiﬁcant difference in the precision of both imag-
ing techniques. Pearson’s r was 0.798, showing a strong correla-
tion between both MRI and CT (Fig. 3).
Intraclass Correlations
The lead tip two-rater interobserver ICC showed an almost per-
fect agreement for both iCT and MRI measurements, 0.999 (95%
CI; range: 0.699-1.000) and 0.995 (95% CI; range: 0.940-0.998),
respectively.
DISCUSSION
Ideally, proper visualization of the DBS lead and the nucleus bor-
ders of the target would either ensure correct lead position or shed
light upon the need for revision. Unfortunately, the current imaging
techniques have not reached the stage in which both DBS lead
and nucleus borders can be clearly visualized. MRI offers detailed
visualization of relevant brain structures, but also induces an arti-
fact that overestimates the actual electrode. Besides, DBS systems
are not always compatible with MRI and occurrence of adverse
events have been described in DBS implanted patients after MRI
(24). Also, the speciﬁc absorption rate limits implemented in MRI
safety protocols as a result of these concerns can limit the quality
of the images (depending on sequence), resulting in suboptimal
images for lead veriﬁcation. In addition, access to an intraoperative
MRI suite is limited in most hospitals. All the more reason for the
entry of an alternative imaging modality in DBS surgery.
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All leads Euclidean distance 0.98  0.49 0.14-2.58
X 0.35  0.25 0.00-1.20
Y 0.61  0.52 0.00-2.50
Z 0.49  0.39 0.00-1.80
Left lead Euclidean distance 0.97  0.47 0.36-2.58
X 0.33  0.21 0.00-0.80
Y 0.59  0.53 0.00-2.50
Z 0.51  0.34 0.00-1.20
Right lead Euclidean distance 1.00  0.53 0.14-2.04
X 0.36  0.29 0.00-1.20
Y 0.63  0.51 0.00-2.00
Z 0.47  0.44 0.10-1.80
Figure 3. Linear Deming regression plot indicating good agreement
between iCT and MRI. [Color ﬁgure can be viewed at wileyonlinelibrary.com]
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Our study shows that iCT is noninferior to MRI for the veriﬁcation
of lead position in DBS surgery. The average Euclidean distance
between lead tip position determined on iCT and MRI was
0.98 mm  0.49 mm, which is lower than the noninferiority margin
for signiﬁcant clinical relevance.
The differences found in this study are smaller than those found in
other studies on lead localization in DBS. Shahlaie et al. (20) found dif-
ferences of 1.65  0.19 mm between lead tips on iCT and postopera-
tive MRI. Based on the conclusions of previous publications (16,18,20)
and the results obtained in this article, the authors agree that iCT
could replace postoperative MRI in assessing DBS leads. Lee et al. (10)
directly fused postoperative CT and postoperative MRI and subse-
quently compared the lead centers at ﬁve different levels. The lead
centers showed differences of 1.08 mm to 1.40 mm. Thani et al. (22)
performed intraoperative MRI with a surrogate marker (carbothane
stylette, in which the lead was placed later) and fused this dataset
with postoperative CT (with DBS electrodes) to calculate the discrep-
ancy between the location of the active contact of the two images.
The discrepancy found was 1.60  0.20 mm. Carlson et al. (21)
reported a distance of 1.43  0.66 mm comparing postoperative MRI
(1-2 weeks) and postoperative CT (12 hours).
Besides studying the difference of the lead tip position on iCT
and MRI, the difference between the lead and the intended target
was assessed on each modality, because this information is very
important for the intraoperative decision to revise the lead or not.
Larger Euclidean distances were found between target and DBS
lead on MRI, compared to iCT (1.94  0.74 mm vs. 1.71  0.61 mm).
This difference between modalities is most likely caused by the
difﬁculty both lead tip assessors experienced identifying the
lead tip on MRI. The often unclear black artifact was not well-
delineated and showed a gradual beginning at the lead tip, mak-
ing it difﬁcult to accurately mark the lead tip. Difﬁculty visualizing
the lead tip on MRI imaging has been described before (16,18).
Assessing Lead Position Based on Artifact Visualization
On both CT and MRI the electrode induces an artifact that
exceeds the actual electrode size. To accurately assess lead position-
ing on imaging, it is important to exactly know the electrode posi-
tion in relation to the artifact. On MRI, DBS leads are depicted as
ellipse-shaped low signal artifacts, in which each contact point indi-
vidually induces a symmetrical artifact extending approximately
1.4 mm over the proximal and distal ends of the contact and
1.16 mm over the lateral limit of the contact (11). This suggests that
both the artifact and the relative contact have the same center
(8,11). Pollo et al. thus identiﬁed 1.4 mm to be the distance on MRI
between the distal limit of the artifact and the distal limit of the ﬁrst
contact (contact 0). On CT, lead artifacts appear as a clear, hyper-
dense signal in the darkened (after windowing) intracranial space.
Because of the high spatial ﬁdelity of CT, the artifact is likely to be
concentrically formed around the lead (25). Hemm et al. conducted
a study based on lead artifacts on CT images and found distances
of 1.1 mm and 1.2 mm between the beginning of the artifact and
the distal limit of contact 0, in their in vivo and in vitro study, respec-
tively (12). In our study, the above cited distances were taken into
account when calculating the exact position of the −1/+2 contact
spacing for assessing the lead position relative to target.
Limitations
The position of the lead tip and the lead position relative to the
target was compared between modalities, taken into account the
imaging speciﬁc characteristics of the different lead artifacts.
However, since the distance from lead tip to contact 0 varies
between MRI and CT (1.4 mm vs. 1.2 mm), contact 0 might be
more suitable than the lead tip to compare modalities. Nonethe-
less, the lead tip has been extensively used to study accuracy in
the past (26–29) and a difference of 0.2 mm between modalities
is very small.
Fusion error could have played a role in the accuracy of lead
measurements. When fusion between imaging sets was being
performed, fusion was always visually veriﬁed by checking ven-
tricular and sulcal shape. In none of the cases manual fusion
adjustment was necessary.
Another limitation in our study might be the difference in time
between the iCT and the postoperative MRI (24–72 hours). Ideally,
the postoperative MRI should be performed directly after the iCT
to minimize any effects related to brain shift, but this was not
possible because of logistic reasons. Therefore, brain shift could
have led to a less reliable comparison between both imaging
modalities.
Future Perspectives
The results show that iCT is noninferior to postoperative MRI
for lead localization in DBS surgery. Our institution may therefore
have the possibility of proceeding towards an asleep DBS proce-
dure using iCT, since iCT proves to measure up to the gold stan-
dard, MRI. Good results have been published by recent studies
regarding asleep DBS surgery (30–38). Asleep DBS is proven to be
safe and without differences in adverse events compared to
awake DBS (33). The asleep procedure could possibly be even
more effective (35) and may be cheaper (39) than operating in an
awake situation. Risk of surgical complications such as hemor-
rhages or infections are also signiﬁcantly less frequent in asleep
DBS (32,37).
In the current study, we have proven iCT to be noninferior to
postoperative MRI, whereby our surgical group can advance to
performing asleep surgery in our patients using iCT. The lack of
MRI availability does not hinder the possibility to perform asleep
DBS surgery.
CONCLUSION
In this prospective study iCT was found to be noninferior to
postoperative MRI for the veriﬁcation of the lead position in DBS
surgery. There were no relevant differences between the lead
position on iCT and postoperative MRI. In conclusion, both modal-
ities have their pros and cons, but either one is suitable for lead
position veriﬁcation in DBS surgery.
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